NCT02733380 Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT02732015 Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy Status TERMINATED Phase PHASE2
NCT02726581 An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT02726308 Dexamethasone With Super-hydration for Prevention of Postoperative Nausea and Vomiting Status COMPLETED Phase PHASE2
NCT02725008 Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation Status COMPLETED Phase PHASE3
NCT02723994 A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT02720510 A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) Status TERMINATED Phase PHASE2
NCT02719613 Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab Status COMPLETED Phase PHASE2
NCT02718833 A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02709889 Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02703272 A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE3
NCT02698995 Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia Status COMPLETED Phase PHASE3
NCT02698306 Comparison of the Use of Dexamethasone and Diclofenac Sodium in Immediate Post-Operative Care in Third Molar Surgery Status UNKNOWN Phase NA
NCT02697383 Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study Status COMPLETED Phase PHASE1
NCT02697344 Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02692339 Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase N/A
NCT02692248 Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT Status COMPLETED Phase PHASE2
NCT02690922 Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Status UNKNOWN Phase PHASE4
NCT02685826 A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2